Physician profile
Jonathan D Wolfe
NPI 1598176620
$5,844.07
in general payments reported to CMS, 2019-2025
24 companies · $663 in 2025
The $663 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $349 · 2021: $501 · 2022: $1,668 · 2023: $2,045 · 2024: $192 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,053 · Travel and Lodging: $575 · Grant: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,052.69 |
| Travel and Lodging | $575.00 |
| Grant | $271.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,325.49 | 2019-2025 | Versacross Access Solution, Avvigo Guidance System, Wolverine Coronary Cutting Balloon |
| Philips North America LLC | $805.81 | 2020-2022 | |
| Abiomed | $779.73 | 2021-2025 | Impella |
| Cardiovascular Systems INC. | $451.07 | 2019-2023 | Diamondback Coronary |
| Abbott Laboratories | $373.86 | 2023 | Amplatzer, Diamondback Coronary, Ultreon |
| Biotronik INC. | $336.24 | 2022-2023 | Orsiro Mission |
| Penumbra, INC. | $253.38 | 2019-2023 | Indigo System |
| Shockwave Medical, INC | $225.47 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Asahi Intecc USA, INC. | $184.57 | 2022-2023 | Asahi Ptca Guide Wire |
| Teleflex LLC | $141.61 | 2021 | |
| Medtronic Vascular, INC. | $131.18 | 2020 | |
| Cardiva Medical, INC. | $130.16 | 2022-2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Astrazeneca Pharmaceuticals Lp | $117.13 | 2019 | |
| Medtronic, INC. | $112.61 | 2023 | Onyx Frontier |
| Zoll Circulation INC | $111.17 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $96.27 | 2022 | |
| Chiesi USA, INC. | $79.02 | 2022 | |
| Amgen INC. | $60.32 | 2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.01 | 2020-2023 | Lifevest |
| Leo Pharma INC. | $24.65 | 2024 | Adbry |
| Terumo Medical Corporation | $21.92 | 2023 | Azur Cx Detachable, Glidewire |
| E.R. Squibb & Sons, L.L.C. | $20.89 | 2025 | Eliquis |
| Botanix Sb INC | $20.51 | 2025 | Sofdra |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.